Variant · Snv
CSF3R T618I
CI-VAR-00004332Explore in graph →NP_724781.1:p.Thr618IleNM_156039.3:c.1853C>TClinVar 208339 CIViC 2387 rs796065343
Curated evidence
Evidence by cancer (3 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 32187354
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Acute Myeloid Leukemia1 | ||||||||
| CSF3R T618I | (prognostic) | Prognostic | B | Supports Poor Outcome | 4 | submitted | EID9072Tarlock et al. (2020) report the incidence of CSF3R mutations in a large cohort of pediatric AML; CSF3R mutations almost always cooccured mutually exclusively with either CEBPA variants or t(8;21). Th… (full text at CIViC) PMID 32187354 · Tarlock et al., 2020 · Open in CIViC | civic |
| Chronic Neutrophilic Leukemia2 | ||||||||
| CSF3R T618I | Ruxolitinib | Predictive | C | Supports Sensitivity Response | 4 | accepted | EID6381Case report of a patient treated with ruxolitinib, an FDA-approved JAK1/2 inhibitor, which resulted in dramatic improvement of his blood counts. He also had significant reduction of spleen volume and … (full text at CIViC) PMID 25180155 · | |
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 208339 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Early T cell progenitor acute lymphoblastic leukemia; Autosomal recessive severe congenital neutropenia due to CSF3R deficiency; Neoplasm; Hereditary neutrophilia | germline/somatic | 5 | Oct 31, 2025 | clinvar |